# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $85 to $80.
Canaccord Genuity analyst Kyle Mikson maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $90...
Citigroup analyst Patrick Donnelly maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $100 t...
Wall Street is seeing a day of gains as all major indices traded in the green around noon in New York, driven by a surprising u...
Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday.